IonQ, Inc. Liquidation Value

IonQ, Inc. (period end March 31, 2026) presents a balance sheet that, under a liquidation lens, shows deeply negative equity recovery despite a large reported book equity of approximately $4.99 billion. The asymmetry is driven by three factors: (1) the dominant asset categories are non-cash, non-liquid, and zero-recovery items; (2) a massive warrant liability sits at face value on the liability side; and (3) acquisition-driven intangibles and goodwill bloat the asset base with zero liquidation credit.

On the asset side, total assets of $6.69 billion decompose as follows. Cash and cash equivalents of $494 million recover at 100%. Available-for-sale securities (short-term $1.54 billion, long-term $1.06 billion, total $3.10 billion) are U.S. investment-grade debt securities marked to fair value; recovery is treated at 95-100% given liquidity and short duration. Accounts receivable of $98 million recovers at 90-95%. Inventory of $17 million recovers at 60%. PP&E gross of $195 million less accumulated depreciation of $63 million yields net $132 million; at a 50-60% liquidation haircut, recovery is roughly $66-79 million. Operating lease ROU assets of $23 million recover at zero (offset by lease liabilities). Goodwill of $2.13 billion and finite-lived intangibles net of $781 million recover at zero under the liquidation lens. OtherAssetsNoncurrent of $268 million includes strategic investments and restricted cash; recovery is uncertain and likely heavily discounted.

On the liability side, total liabilities of $1.70 billion include current liabilities of $164 million (accounts payable $38 million, accrued liabilities $65 million, deferred revenue current $51 million, operating lease current $9 million), noncurrent liabilities led by the warrant derivative liability of $1.41 billion (DerivativeLiabilitiesNoncurrent), deferred tax liability of $78 million, operating lease noncurrent $21 million, postemployment benefits $8 million, and other noncurrent liabilities of $99 million. The warrant liability is the critical liability item: it is classified as a derivative and carried at fair value ($1.41 billion); in liquidation it extinguishes at whatever the mark-to-market settlement value is at that date, which under the lens is taken at face. This single line represents the largest liability and is stock-price-sensitive—the Q1 2026 warrant fair value gain of $1.06 billion (driven by mark-to-market) produced the reported GAAP net income of $805 million, but the outstanding warrant liability balance remains $1.41 billion at period end.

Crude liquidation recovery: liquid assets (cash $494M + AFS at ~97% = $3.01B + AR at 92% = $90M + inventory at 60% = $10M + PP&E at 55% = $73M) total approximately $3.68 billion. Against total liabilities at face of $1.70 billion, gross recovery is approximately $1.98 billion before deducting zero-recovery intangibles and goodwill, which are already excluded. However, OtherAssetsNoncurrent ($268M) and deferred revenue ($64M, obligation to perform) complicate the picture. On balance, equity recovery is approximately $2.0-2.3 billion in a clean AFS/cash-dominant scenario, but this ignores the pending SkyWater acquisition commitment of approximately $1.0 billion in cash outflows (not yet on the balance sheet). Post-SkyWater close, the liquidity pool shrinks materially. The filing does not separately tag the SkyWater cash commitment as a recognized liability—it remains a contingent contractual obligation disclosed only in MD&A.

Compared to the prior filing (10-K, December 31, 2025), the key changes are: goodwill increased from approximately $1.96 billion to $2.13 billion (acquisitions of Skyloom and Seed Innovations closed in January 2026), intangibles net increased from approximately $720 million to $781 million, the warrant derivative liability increased substantially, AFS securities grew, and the accumulated deficit improved from a larger deficit position due to the warrant mark-to-market gain.